Yiling Pharmaceutical’s Patent Depression-resolving Drug Approved for Marketing in China
Post Views: 96 According to Yiling Pharmaceutical’s notice on Thursday (UTC+8), the Depression-resolving and Restlessness-relieving Capsules have been approved for marketing via the obtained Drug Registration Certificate issued by China’s National Medical Products Administration (NMPA). The Company owns the full intellectual property rights of the drug. The drug is an innovative traditional Chinese medicine (TCM)…
